The connection between inner ear health and cardiovascular function appears stronger than previously recognized, with new evidence suggesting that blood viscosity changes may accelerate hearing deterioration in chronic vestibular disorders. This finding could reshape how clinicians approach progressive hearing loss prevention.
Analysis of 112 Meniere's disease patients revealed that those with severe hearing impairment showed significantly elevated hematocrit levels—a measure of blood thickness—along with higher hemoglobin concentrations and reduced kidney filtration capacity. Male patients demonstrated particularly pronounced vulnerability, with hematocrit values and uric acid levels emerging as independent predictors of hearing severity when controlling for age and disease duration. The severe group exhibited hearing threshold elevations across all tested frequencies, with even the unaffected ear showing subtle high-frequency deficits.
This research illuminates a potentially modifiable pathway in Meniere's disease progression, where systemic metabolic factors influence inner ear microcirculation. The association between blood viscosity and hearing loss aligns with emerging understanding of how cardiovascular health impacts delicate cochlear blood supply. While Meniere's disease traditionally focuses on endolymphatic hydrops, these findings suggest concurrent attention to hematological parameters could identify patients at risk for accelerated deterioration. The kidney function correlation particularly intrigues, as it may reflect broader vascular compromise affecting both organs. However, the cross-sectional design limits causal interpretation, and the relatively small severe group necessitates larger longitudinal studies. If confirmed, routine monitoring of hematocrit and metabolic markers could enable earlier intervention strategies targeting systemic contributors to inner ear pathology.